4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-022983
President and CEO sold 10,177 shares at an average $5.02 ($51,110)
- President and CEO acquired 10,177 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doerfler Douglas President and CEO | 2023-03-31 | Option exercise 10b5-1 | +2,607 | $0.04 | $104 | 335,804 | D: show line 1 in the form |
| Doerfler Douglas President and CEO | 2023-03-31 | Sale 10b5-1 | −2,607 | $5.00 | $13,035 | 333,197 | D: show line 2 in the form |
| Doerfler Douglas President and CEO | 2023-04-03 | Option exercise 10b5-1 | +100 | $0.04 | $4 | 333,297 | D: show line 3 in the form |
| Doerfler Douglas President and CEO | 2023-04-03 | Sale 10b5-1 | −100 | $5.01 | $501 | 333,197 | D: show line 4 in the form |
| Doerfler Douglas President and CEO | 2023-04-04 | Option exercise 10b5-1 | +7,470 | $0.04 | $299 | 340,667 | D: show line 5 in the form |
| Doerfler Douglas President and CEO | 2023-04-04 | Sale 10b5-1 | −7,470 | $5.03 | $37,574 | 333,197 | D: show line 6 in the form |
| Open-market sales · 10,177 sh · avg $5.02 · $51,110 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doerfler Douglas President and CEO | 2023-03-31 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,607 | 382,473 | D: show line 7 in the form | ||
| Doerfler Douglas President and CEO | 2023-04-03 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −100 | 382,373 | D: show line 8 in the form | ||
| Doerfler Douglas President and CEO | 2023-04-04 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −7,470 | 374,903 | D: show line 9 in the form |
Loading xslF345X04/doc4.xml…